Document Detail


Biologic response modifiers: relevance & repercussions.
MedLine Citation:
PMID:  22054751     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Biologic response modifiers (BRMs) are substances that occur naturally in the body. They can also be manufactured in the laboratory and then administered as targeted therapy. Undoubtedly BRMs will find expanded role in terminal illness like cancer where other therapies have failed. However, great caution must be exercised in prescribing these agents in chronic indolent diseases where potential for ultimate harm might outweigh short-term benefits.
Authors:
Romesh Khardori; Nancy Misri Khardori
Publication Detail:
Type:  Journal Article     Date:  2011-09-25
Journal Detail:
Title:  Infectious disease clinics of North America     Volume:  25     ISSN:  1557-9824     ISO Abbreviation:  Infect. Dis. Clin. North Am.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-11-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804508     Medline TA:  Infect Dis Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  719-22     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Division of Endocrinology & Metabolism, Eastern Virginia Medical School, 825 Fairfax Avenue, Norfolk, VA 23507, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of castration on bovine muscle composition.
Next Document:  Overview of biologic response modifiers in infectious disease.